Drug | n (%) |
---|---|
Antipsychotic (n = 90) | |
Yes | 83 (92.2) |
No | 7 (7.8) |
One antipsychotic | 71 (78.8) |
Combination antipsychotic | 12 (13.3) |
Typical or atypical agent (n = 71) | |
Typical | 16 (22.5) |
Zuclopenthixol | 2 (2.8) |
Flupenthixol | 5 (7.0) |
Haloperidol | 1 (1.4) |
Fluphenazine | 1 (1.4) |
Pipothiazine | 1 (1.4) |
Sulpiride | 4 (5.6) |
Trifluoperazine | 2 (2.8) |
Atypical | 55 (77.5) |
Amisulpiride | 3 (4.2) |
Clozapine | 7 (9.9) |
Olanzapine | 29 (40.8) |
Quetiapine | 8 (11.3) |
Risperidone | 8 (11.3) |
Non-antipsychotic psychotropic drugs (n = 90) | |
Antidepressants | |
SSRI | 29 (32.2) |
SNRI | 9 (10) |
NaSSA | 4 (4.4) |
TCA | 7 (7.8) |
MAOI | 3 (3.3) |
Mood Stabiliser | |
Valproate | 16 (17.8) |
Lamotrigine | 8 (8.9) |
Carbamazepine | 1 (1.1) |
Lithium | 15 (16.7) |
Other | |
Gabapentin | 2 (2.2) |
Benzodiazepines | 28 (31.1) |
Tryptophan | 2 (2.2) |
Anticholinergic agent | 15 (16.7) |
Non-psychotropic drugs (n = 90) | |
Antihypertensive agent | 13 (14.4) |
Thyroxine | 10 (11.1) |
Hypoglycaemic agent | 4 (4.4) |